by Elena Iemma | Jan 12, 2026 | Blog, News
In 2025, EpiVax advanced the science of immunogenicity assessment through AI-driven ADA prediction, enhanced in silico tools, expanded in vitro assays and consulting offerings, and new regulatory frameworks supporting biologics and generic peptides. Advancing...
by Elena Iemma | Feb 24, 2025 | Blog
We know, and We Care There is not a lot of room in the TOL (Thinking out Loud) Newsletter to share our feelings about the news in the USA, but we want you to know that we ARE aware, and we REALLY CARE about the negative impact of recent...
